How much funding has Oxbridge Clinical raised?

Oxbridge Clinical has raised $4.5M in total funding, most recently a Seed round.

Who are Oxbridge Clinical's investors?

Oxbridge Clinical's investors include Steele Foundation for Hope.

Where is Oxbridge Clinical headquartered?

Oxbridge Clinical is headquartered in Boston, Massachusetts, United States.

What industry is Oxbridge Clinical in?

Oxbridge Clinical operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does Oxbridge Clinical have?

Oxbridge Clinical has 1-10 employees.

Oxbridge Clinical

On-site, germ-specific diagnosis and antibiograms—faster, cheaper, simpler

Boston, United States · $4.5M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: Boston, Massachusetts
Employees: 1–10
Business Model: B2B
Website: oxbridgeclinical.com

Total Funding: $4.5M
Last Round: $4.5M SeedOct 2025
Rounds: 1

About

Oxbridge Clinical is a biotech startup developing an ultra-low-cost, pocket-sized diagnostic platform that detects bacteria, viruses, and fungi directly from raw samples at the point of care in under 15 minutes, without requiring a lab, molecular reagents, or complex infrastructure. The platform combines solid-state micropore sensing with an AI engine to deliver lab-grade accuracy and rapid antibiograms—a germ-specific resistance profile—at a per-test cost far below PCR. Founded by Giulio Deangeli, Cristiano Peron, and Fidelius von Rehlingen-Prinz, the company is headquartered in Boston and is a resident of The Engine, MIT's tough-tech incubator.

Summary

Oxbridge Clinical is an Artificial Intelligence company based in Boston, United States. It has raised $4.5M in total across 1 round, most recently a $4.5M Seed round in Oct 2025. Investors include Steele Foundation for Hope.